SEC Filings | Clearside Biomedical, Inc.- IR Site

Filing date	Form	Description	View
Nov 03, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0000950170-23-058627.pdf 0000950170-23-058627.rtf 0000950170-23-058627.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
Nov 01, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000933430-23-000012.pdf 0000933430-23-000012.rtf
Nov 01, 2023	3	Initial filing by director officer or owner of more than ten percent	View HTML 0000933430-23-000011.pdf 0000933430-23-000011.rtf 0000933430-23-000011.xls
Nov 01, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0000933430-23-000013.pdf 0000933430-23-000013.rtf 0000933430-23-000013.xls
Oct 04, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-23-052027.pdf 0001209191-23-052027.rtf 0001209191-23-052027.xls
Sep 29, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0000950170-23-050819.pdf 0000950170-23-050819.rtf 0000950170-23-050819.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
Sep 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-23-050480.pdf 0001209191-23-050480.rtf 0001209191-23-050480.xls
Sep 22, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-23-050381.pdf 0001209191-23-050381.rtf 0001209191-23-050381.xls
Sep 20, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-23-050161.pdf 0001209191-23-050161.rtf 0001209191-23-050161.xls
Sep 20, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-23-050162.pdf 0001209191-23-050162.rtf 0001209191-23-050162.xls

Data provided by Kaleidoscope.